2007
The Role of the Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Cytokine System in Primary Hyperparathyroidism
Nakchbandi IA, Lang R, Kinder B, Insogna KL. The Role of the Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Cytokine System in Primary Hyperparathyroidism. The Journal Of Clinical Endocrinology & Metabolism 2007, 93: 967-973. PMID: 18073309, PMCID: PMC2266956, DOI: 10.1210/jc.2007-1645.Peer-Reviewed Original ResearchConceptsNuclear factor-kappaB ligandPrimary hyperparathyroidismBone lossReceptor activatorTotal femurIL-6Bone resorptionIL-6 soluble receptorMild primary hyperparathyroidismBone mineral densitySoluble receptor activatorMechanism of actionIL-6sRSRANKL levelsSerum levelsBone turnoverMineral densityCytokine systemSoluble receptorHyperparathyroidismNormal rangeSkeletal responsivenessBiochemical markersPatientsGreater risk
2004
Hypercalcemia and Hypercalcemia Treatment
Kinder B. Hypercalcemia and Hypercalcemia Treatment. 2004, 517-529. DOI: 10.1016/b0-12-475570-4/00643-0.Peer-Reviewed Original ResearchGastrointestinal calcium absorptionNormal calcium regulationRenal calcium excretionUrgent clinical problemHypercalcemia treatmentCalcium excretionRole of calciumCalcium absorptionNew bone formationBone resorptionClinical problemHypercalcemiaAppropriate managementBone formationCalcium regulationHomeostatic systemPatientsExcretionResorption